116 related articles for article (PubMed ID: 38876123)
1. Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study.
Saha A; Bosma JS; Twilt JJ; van Ginneken B; Bjartell A; Padhani AR; Bonekamp D; Villeirs G; Salomon G; Giannarini G; Kalpathy-Cramer J; Barentsz J; Maier-Hein KH; Rusu M; Rouvière O; van den Bergh R; Panebianco V; Kasivisvanathan V; Obuchowski NA; Yakar D; Elschot M; Veltman J; Fütterer JJ; de Rooij M; Huisman H;
Lancet Oncol; 2024 Jun; ():. PubMed ID: 38876123
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study.
Lång K; Josefsson V; Larsson AM; Larsson S; Högberg C; Sartor H; Hofvind S; Andersson I; Rosso A
Lancet Oncol; 2023 Aug; 24(8):936-944. PubMed ID: 37541274
[TBL] [Abstract][Full Text] [Related]
3. Detection and PI-RADS classification of focal lesions in prostate MRI: Performance comparison between a deep learning-based algorithm (DLA) and radiologists with various levels of experience.
Youn SY; Choi MH; Kim DH; Lee YJ; Huisman H; Johnson E; Penzkofer T; Shabunin I; Winkel DJ; Xing P; Szolar D; Grimm R; von Busch H; Son Y; Lou B; Kamen A
Eur J Radiol; 2021 Sep; 142():109894. PubMed ID: 34388625
[TBL] [Abstract][Full Text] [Related]
4. Changes in cancer detection and false-positive recall in mammography using artificial intelligence: a retrospective, multireader study.
Kim HE; Kim HH; Han BK; Kim KH; Han K; Nam H; Lee EH; Kim EK
Lancet Digit Health; 2020 Mar; 2(3):e138-e148. PubMed ID: 33334578
[TBL] [Abstract][Full Text] [Related]
5. Effect of Prostate MRI Interpretation Experience on PPV Using PI-RADS Version 2: A 6-Year Assessment Among Eight Fellowship-Trained Radiologists.
Salka BR; Shankar PR; Troost JP; Khalatbari S; Davenport MS
AJR Am J Roentgenol; 2022 Sep; 219(3):453-460. PubMed ID: 35319914
[No Abstract] [Full Text] [Related]
6. PI-RADS
Yu R; Jiang KW; Bao J; Hou Y; Yi Y; Wu D; Song Y; Hu CH; Yang G; Zhang YD
Br J Cancer; 2023 Apr; 128(6):1019-1029. PubMed ID: 36599915
[TBL] [Abstract][Full Text] [Related]
7. Interactive Explainable Deep Learning Model Informs Prostate Cancer Diagnosis at MRI.
Hamm CA; Baumgärtner GL; Biessmann F; Beetz NL; Hartenstein A; Savic LJ; Froböse K; Dräger F; Schallenberg S; Rudolph M; Baur ADJ; Hamm B; Haas M; Hofbauer S; Cash H; Penzkofer T
Radiology; 2023 May; 307(4):e222276. PubMed ID: 37039688
[TBL] [Abstract][Full Text] [Related]
8. Artificial intelligence for breast cancer detection in screening mammography in Sweden: a prospective, population-based, paired-reader, non-inferiority study.
Dembrower K; Crippa A; Colón E; Eklund M; Strand F;
Lancet Digit Health; 2023 Oct; 5(10):e703-e711. PubMed ID: 37690911
[TBL] [Abstract][Full Text] [Related]
9. Performance of Artificial Intelligence-Aided Diagnosis System for Clinically Significant Prostate Cancer with MRI: A Diagnostic Comparison Study.
Jiang KW; Song Y; Hou Y; Zhi R; Zhang J; Bao ML; Li H; Yan X; Xi W; Zhang CX; Yao YF; Yang G; Zhang YD
J Magn Reson Imaging; 2023 May; 57(5):1352-1364. PubMed ID: 36222324
[TBL] [Abstract][Full Text] [Related]
10. PI-RADS Versions 2 and 2.1: Interobserver Agreement and Diagnostic Performance in Peripheral and Transition Zone Lesions Among Six Radiologists.
Bhayana R; O'Shea A; Anderson MA; Bradley WR; Gottumukkala RV; Mojtahed A; Pierce TT; Harisinghani M
AJR Am J Roentgenol; 2021 Jul; 217(1):141-151. PubMed ID: 32903060
[No Abstract] [Full Text] [Related]
11. Artificial intelligence as diagnostic aiding tool in cases of Prostate Imaging Reporting and Data System category 3: the results of retrospective multi-center cohort study.
Wang K; Xing Z; Kong Z; Yu Y; Chen Y; Zhao X; Song B; Wang X; Wu P; Wang X; Xue Y
Abdom Radiol (NY); 2023 Dec; 48(12):3757-3765. PubMed ID: 37740046
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Accuracy and Interobserver Agreement of PI-RADS Version 2 and Version 2.1 for the Detection of Transition Zone Prostate Cancers.
Wei CG; Zhang YY; Pan P; Chen T; Yu HC; Dai GC; Tu J; Yang S; Zhao WL; Shen JK
AJR Am J Roentgenol; 2021 May; 216(5):1247-1256. PubMed ID: 32755220
[No Abstract] [Full Text] [Related]
13. Likert vs PI-RADS v2: a comparison of two radiological scoring systems for detection of clinically significant prostate cancer.
Khoo CC; Eldred-Evans D; Peters M; Bertoncelli Tanaka M; Noureldin M; Miah S; Shah T; Connor MJ; Reddy D; Clark M; Lakhani A; Rockall A; Hosking-Jervis F; Cullen E; Arya M; Hrouda D; Qazi H; Winkler M; Tam H; Ahmed HU
BJU Int; 2020 Jan; 125(1):49-55. PubMed ID: 31599113
[TBL] [Abstract][Full Text] [Related]
14. Detection of ISUP ≥2 prostate cancers using multiparametric MRI: prospective multicentre assessment of the non-inferiority of an artificial intelligence system as compared to the PI-RADS V.2.1 score (CHANGE study).
Rouvière O; Souchon R; Lartizien C; Mansuy A; Magaud L; Colom M; Dubreuil-Chambardel M; Debeer S; Jaouen T; Duran A; Rippert P; Riche B; Monini C; Vlaeminck-Guillem V; Haesebaert J; Rabilloud M; Crouzet S
BMJ Open; 2022 Feb; 12(2):e051274. PubMed ID: 35140147
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H;
Lancet Oncol; 2021 Sep; 22(9):1240-1249. PubMed ID: 34391509
[TBL] [Abstract][Full Text] [Related]
16. Combining the strengths of radiologists and AI for breast cancer screening: a retrospective analysis.
Leibig C; Brehmer M; Bunk S; Byng D; Pinker K; Umutlu L
Lancet Digit Health; 2022 Jul; 4(7):e507-e519. PubMed ID: 35750400
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial.
Boschheidgen M; Albers P; Schlemmer HP; Hellms S; Bonekamp D; Sauter A; Hadaschik B; Krilaviciute A; Radtke JP; Seibold P; Lakes J; Arsov C; Gschwend JE; Herkommer K; Makowski M; Kuczyk MA; Wacker F; Harke N; Debus J; Körber SA; Benner A; Kristiansen G; Giesel FL; Antoch G; Kaaks R; Becker N; Schimmöller L
Eur Urol; 2024 Feb; 85(2):105-111. PubMed ID: 37863727
[TBL] [Abstract][Full Text] [Related]
18. Deep learning-assisted prostate cancer detection on bi-parametric MRI: minimum training data size requirements and effect of prior knowledge.
Hosseinzadeh M; Saha A; Brand P; Slootweg I; de Rooij M; Huisman H
Eur Radiol; 2022 Apr; 32(4):2224-2234. PubMed ID: 34786615
[TBL] [Abstract][Full Text] [Related]
19. Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1.
Brembilla G; Dell'Oglio P; Stabile A; Damascelli A; Brunetti L; Ravelli S; Cristel G; Schiani E; Venturini E; Grippaldi D; Mendola V; Rancoita PMV; Esposito A; Briganti A; Montorsi F; Del Maschio A; De Cobelli F
Eur Radiol; 2020 Jun; 30(6):3383-3392. PubMed ID: 32052171
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Performance and Interobserver Consistency of the Prostate Imaging Reporting and Data System Version 2: A Study on Six Prostate Radiologists with Different Experiences from Half a Year to 17 Years.
Ke Z; Wang L; Min XD; Feng ZY; Kang Z; Zhang PP; Li BS; You HJ; Hou SC
Chin Med J (Engl); 2018 Jul; 131(14):1666-1673. PubMed ID: 29998885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
